IDiyas

For the Inventor, By the Inventor

Tokyo, Japan

Koichi Fujimoto

USPTO Granted Patents = 23

Average Co-Inventor Count = 5.5

ph-index = 8

Forward Citations = 195(Granted Patents)


Location History:

  • Hiromachi, JP (1984)
  • Tokyo, JP (1987 - 2000)
  • Yokohama, JP (1998 - 2006)

Company Filing History:

goldMedal23 out of 613 
 
Sankyo Company, Limited
 patents

Years Active: 1984-2006

Loading Chart...
23 patents (USPTO):Explore Patents
1. 7030138 - Benzamidine derivatives (2006-04-18),
2. 6555556 - Benzamidine derivatives (2003-04-29),
3. 6117893 - Heterocyclic compounds having anti-diabetic activity and their use (2000-09-12),
4. 5977365 - Heterocyclic compound having anti-diabetic activity (1999-11-02),
5. 5972959 - Oxime derivatives, their preparation and their therapeutic use (1999-10-26),
6. 5962470 - Heterocyclic compounds having anti-diabetic activity and their use (1999-10-05),
7. 5886014 - Benzimidazole derivatives, their preparation and their therapeutic use (1999-03-23),
8. 5843983 - Diphenylethane compounds containing a saturated heterocyclic group, (1998-12-01),
9. 5834501 - Heterocyclic compounds having anti-diabetic activity and their use (1998-11-10),
10. 5780490 - Oxime derivatives, their preparation and their therapeutic use (1998-07-14),
11. 5739345 - Intermediate compounds in the preparation of heterocyclic compounds (1998-04-14),
12. 5703096 - Oxime derivatives, their preparation and their therapeutic use (1997-12-30),
13. 5688823 - Thiazolidine and oxazolidine derivatives their preparation and their (1997-11-18),
14. 5624935 - Heterocyclic compounds having anti-diabetic activity and their use (1997-04-29),
15. 5616599 - Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their (1997-04-01),

Title: The Innovative Contributions of Koichi Fujimoto

Introduction: Koichi Fujimoto is a distinguished inventor based in Tokyo, Japan, known for his substantial contribution to the field of pharmaceutical inventions. With an impressive portfolio of 23 patents, Fujimoto has demonstrated his commitment to advancing medical science and technology through innovation.

Latest Patents: Among his latest inventions are the benzamidine derivatives, which are compounds that exhibit significant pharmacological properties. These derivatives include a variety of functional groups and are designed to possess excellent activated blood coagulation factor X inhibitory activity. This innovation holds promise in the prevention and treatment of blood coagulation-related diseases, showcasing Fujimoto's focus on addressing critical health challenges through his work.

Career Highlights: Throughout his career, Fujimoto has focused on the development of pharmaceutical compounds that can impact patient care positively. His role at Sankyo Company, Limited, a reputable leader in the pharmaceutical industry, has enabled him to push the boundaries of drug discovery and development.

Collaborations: Fujimoto has collaborated with eminent colleagues such as Hiroaki Yanagisawa and Takashi Fujita. These partnerships have enhanced his research efforts and contributed to the successful development of his patented inventions. Working alongside talented individuals has allowed him to pool resources and expertise, ultimately leading to groundbreaking advances in pharmaceutical applications.

Conclusion: Koichi Fujimoto's work exemplifies the spirit of innovation and dedication found within the field of inventorship. His contributions, particularly in developing benzamidine derivatives, highlight the importance of continuous research and collaboration in tackling healthcare challenges. As he continues his work at Sankyo Company, Limited, his future inventions are anticipated to further influence the landscape of medical science positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…